Updated Jul 16, 2026
Eylward Susan has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $22K.
Susan Eylward serves as the General Counsel and Corporate Secretary at Imunon, Inc., a clinical-stage biotechnology company. She has been involved in the company's legal and corporate governance matters, contributing to its focus on innovative treatments.
| Role | General Counsel and Corp Sec |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | IMNN | Imunon, Inc. | S — Open-market sale | 920 | $1.88 | $2K |
| 2026-07-07 | IMNN | Imunon, Inc. | A — Grant or award | 920 | $1.91 | $2K |
| 2026-06-29 | IMNN | Imunon, Inc. | S — Open-market sale | 11.8K | $1.75 | $21K |
| 2026-06-29 | IMNN | Imunon, Inc. | A — Grant or award | 14.7K | $1.72 | $25K |
Susan Eylward serves as the General Counsel and Corporate Secretary at Imunon, Inc., a clinical-stage biotechnology company. She has been involved in the company's legal and corporate governance matters, contributing to its focus on innovative treatments.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($22K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Eylward Susan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.